drugset / Trial / NCT06237231

Efficacy and Safety of DIT112 in the Treatment of Moderate to Severe Pain After Dental Surgery for the Extraction of Impacted Third Molars

NCT06237231

Phase 3 Not yet recruiting 252 enrolled EMS
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of DIT112 in adolescents and adults with acute pain after dental surgery for the extraction of impacted third molars.

Timeline

Start
2025-02-15
Primary completion
2025-03-15
Completion
2027-04-10

Drugs

EvaluationDrugModalityDoseRoute
Subject DIT112 Unknown Oral
Comparator Tramadol Other / unclassified 50 mg Oral
Comparator dipyrone Unknown 1 mg Oral

Indications

No indication recorded.